Discovery of aryl aminoquinazoline pyridones as potent selective, and orally efficacious inhibitors of receptor tyrosine kinase c-Kit

被引:38
|
作者
Hu, Essa [1 ,7 ]
Tasker, Andrew [1 ,7 ]
White, Ryan D. [1 ,7 ]
Kunz, Roxanne K. [1 ,7 ]
Human, Jason [1 ,7 ]
Chen, Ning [1 ,7 ]
Buerli, Roland [1 ,7 ]
Hungate, Randall [1 ,7 ]
Novak, Perry [5 ,8 ]
Itano, Andrea [2 ]
Zhang, Xuxia [2 ]
Yu, Violeta [3 ]
Nguyen, Yen [3 ]
Tudor, Yanyan [3 ]
Plant, Matthew [2 ]
Flynn, Shaun [3 ]
Xu, Yang [4 ]
Meagher, Kristin L. [6 ]
Whittington, Douglas A. [6 ]
Ng, Gordon Y. [2 ]
机构
[1] Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Dept Inflammat, Thousand Oaks, CA 91320 USA
[3] Amgen Inc, Dept HTS & Mol Pharmacol, Thousand Oaks, CA 91320 USA
[4] Amgen Inc, Dept Pharmacokinet & Drug Metab, Thousand Oaks, CA 91320 USA
[5] Amgen Inc, Dept Small Mol Proc Dev, Thousand Oaks, CA 91320 USA
[6] Amgen Inc, Dept Mol Struct, Thousand Oaks, CA 91320 USA
[7] Amgen Inc, Dept Med Chem, Cambridge, MA 02139 USA
[8] Amgen Inc, Dept Small Mol Proc Dev, Cambridge, MA 02139 USA
关键词
D O I
10.1021/jm800188g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Inhibition of c-Kit has the potential to treat mast cell associated fibrotic diseases. We report the discovery of several aminoquinazoline pyridones that are potent inhibitors of c-Kit with greater than 200-fold selectivity against KDR, p38, Lck, and Src. In vivo efficacy of pyridone 16 by dose-dependent inhibition of histamine release was demonstrated in a rodent pharmacodynamic model of mast cell activation.
引用
收藏
页码:3065 / 3068
页数:4
相关论文
共 50 条
  • [21] The c-kit receptor tyrosine kinase: Its role in hematological malignancies
    Kanakura, Y
    Ikeda, H
    Tsujimura, T
    Kitayama, H
    CANCER JOURNAL - FRANCE, 1996, 9 (02): : 79 - 82
  • [22] Discovery of GS-9973: A selective and orally efficacious inhibitor of spleen tyrosine kinase (Syk)
    Mitchell, Scott A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [23] Discovery of 2-amino-3-amido-5-aryl-pyridines as highly potent, orally bioavailable, and efficacious PERK kinase inhibitors
    Calvo, Veronica
    Surguladze, David
    Li, An-Hu
    Surman, Matthew D.
    Malibhatla, Srikanth
    Bandaru, Madhavarao
    Jonnalagadda, Suresh Krishna
    Adarasandi, Ravi
    Velmala, Madhusudhan
    Singireddi, Durga Rama Prasad
    Velpuri, Mahendar
    Nareddy, Bhaskar Reddy
    Sastry, Visweswara
    Mandati, Chiranjeevi
    Guguloth, Rambabu
    Siddiqui, Shapi
    Patil, Basanagoud S.
    Chad, Elena
    Wolfley, Jennifer
    Gasparek, Jennifer
    Feldman, Kirsten
    Betzenhauser, Matthew
    Wiens, Brent
    Koszelak-Rosenblum, Mary
    Zhu, Guangyu
    Du, Hongwen
    Rigby, Alan C.
    Mulvihill, Mark J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 43
  • [24] Discovery of potent and selective reversible Bruton?s tyrosine kinase inhibitors
    Qiu, Hui
    Ali, Zahid
    Bender, Andrew
    Caldwell, Richard
    Chen, Yi-Ying
    Fang, Zhizhou
    Gardberg, Anna
    Glaser, Nina
    Goettsche, Anja
    Goutopoulos, Andreas
    Grenningloh, Roland
    Hanschke, Bettina
    Head, Jared
    Johnson, Theresa
    Jones, Christopher
    Jones, Reinaldo
    Kulkarni, Shashank
    Maurer, Christine
    Morandi, Federica
    Neagu, Constantin
    Poetzsch, Sven
    Potnick, Justin
    Schmidt, Ralf
    Roe, Katherine
    Follis, Ariele Viacava
    Wing, Carolyn
    Zhu, Xiaohua
    Sherer, Brian
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 40
  • [25] Discovery of potent and selective orally active inhibitors of anaplastic lymphoma kinase (ALK)
    Shakespeare, William
    Fantin, Valeria
    Wang, Frank
    Kohlmann, Anna
    Liu, Shuangying
    Huang, Wei-Sheng
    Wang, Yihan
    Zou, Dong
    Thomas, Mathew
    Li, Feng
    Qi, Jiwei
    Cai, Lisi
    Dwight, Thimothy
    Xu, Yongjin
    Xu, Rongsong
    Dodd, Rory
    Xu, Qihong
    Anjum, Rana
    Zhang, Sen
    Keats, Jeffrey
    Xue, Ling
    Wardwell, Scott
    Ning, Yaoyu
    Moran, Lauren
    Mohemmad, Qurish
    Zhu, Xiaotian
    Narasimhan, Narayana
    Rivera, Victor
    Dalgarno, David
    Clackson, Tim
    CANCER RESEARCH, 2009, 69
  • [26] Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases
    Ma, Bin
    Bohnert, Tonika
    Otipoby, Kevin L.
    Tien, Eric
    Arefayene, Million
    Bai, Judy
    Bajrami, Bekim
    Bame, Eris
    Chan, Timothy R.
    Humora, Michael
    MacPhee, J. Michael
    Marcotte, Douglas
    Mehta, Devangi
    Metrick, Claire M.
    Moniz, George
    Polack, Evelyne
    Poreci, Urjana
    Prefontaine, Annick
    Sheikh, Sarah
    Schroeder, Patricia
    Smirnakis, Karen
    Zhang, Lei
    Zheng, Fengmei
    Hopkins, Brian T.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (21) : 12526 - 12541
  • [27] Discovery of a potent, highly selective, and orally efficacious small-molecule activator of the insulin receptor
    Liu, K
    Xu, LB
    Szalkowski, D
    Li, ZH
    Ding, V
    Kwei, G
    Huskey, S
    Moller, DE
    Heck, JV
    Zhang, BB
    Jones, AB
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (19) : 3487 - 3494
  • [28] Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors
    Deng, Hongfeng
    Zhou, Jingye
    Sundersingh, Flora
    Messer, Jeffrey A.
    Somers, Donald O.
    Ajakane, Myriam
    Arico-Muendel, Christopher C.
    Beljean, Arthur
    Belyanskaya, Svetlana L.
    Bingham, Ryan
    Blazensky, Emily
    Boullay, Anne-Benedicte
    Boursier, Eric
    Chai, Jing
    Carter, Paul
    Chung, Chun-Wa
    Daugan, Alain
    Ding, Yun
    Herry, Kenny
    Hobbs, Clare
    Humphries, Eric
    Kollmann, Christopher
    Van Loc Nguyen
    Nicodeme, Edwige
    Smith, Sarah E.
    Dodic, Nerina
    Ancellin, Nicolas
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (04): : 379 - 384
  • [29] Discovery of Amino Alcohols as Highly Potent, Selective, and Orally Efficacious Inhibitors of Leukotriene A4 Hydrolase
    Thoma, Gebhard
    Markert, Christian
    Lueoend, Rainer
    Miltz, Wolfgang
    Spanka, Carsten
    Bollbuck, Birgit
    Wolf, Romain M.
    Srinivas, Honnappa
    Penno, Carlos A.
    Kiffe, Michael
    Gajewska, Monika
    Bednarczyk, Dallas
    Wieczorek, Grazyna
    Evans, Amanda
    Beerli, Christian
    Rohn, Till A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (23) : 16410 - 16425
  • [30] Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors
    Yang, Yaxi
    Zhang, Rukang
    Li, Zhaojun
    Mei, Lianghe
    Wan, Shili
    Ding, Hong
    Chen, Zhifeng
    Xing, Jing
    Feng, Huijin
    Han, Jie
    Jiang, Hualiang
    Zheng, Mingyue
    Luo, Cheng
    Zhou, Bing
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (03) : 1337 - 1360